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ANNA'S LIFX EXPECTANCY 
J.M. Owen and J.W. Vaupel 
Every year  the  Office of t he  Actuary of the  U.S. Department of Health and Human 
Services releases an estimate of t h e  life expectancy for a newborn child: the most 
recent  figure for a female was 78 years,  and for a male, 71 years  [I]. But this number 
assumes tha t  over t h e  course of t he  child's life there  will be no fur ther  progress 
against mortality, an  improbable supposition indeed. The actuaries  who calculate offi- 
cial life expectancy estimates assume a baby born in a given year  will experience the  
mortality rates  for every age of t ha t  year throughout he r  life. 
On March 20 of 1984 Anna Bodil Vaupel was born. The Off'ice of the Actuary would 
0 
give her  a life expectancy, or what demographers denote by eo, of not  much over 78. 
A.B., however, should live much longer than  that.  Throughout this  century  grea t  pro- 
gress has been made against mortality in medicine, public heal th,  sanitation, nutr i -  
t ion, safety, and  other  areas,  and  i t  seems implausible to  suppose such progress will 
come to a ha l t  now. There are several ways of thinking about t h e  continuation of this 
progress, and  here  we shall look a t  three: continued progress a t  the  same ra tes ,  
accelerated progress, and cause-specific, or disease-by-disease, progress. We will base 
our  estimates on rough calculations tha t  a re  hopeful in tha t  we ignore catastrophes 
such as nuclear  war.* Although the  estimat,es a re  approximate, t he  message is clear: 
Anna's life expectancy and the  life expectancies of o ther  newborn girls and  boys is 
probably many years longer than the  official estimates. 
SEADY PROGRESS 
If progress against mortality a t  each age continues a t  t he  same rates  as  in the  
1970s, how long can Anna B. expect t o  live? I t  tu rns  out t ha t  if we do assume such 
steady progress against mortality, he r  expected life span is 90 years,  fully 12 years 
more than official estimates give her. If corlditions improve a t  the  same rates indefin- 
itely and Anna has a daughter a t  age 25, her  daughter can expect to  live to be 94. If 
t he  daughter  has a daughter  under  t h e  same conditions, Anna's granddaughter has  an  
expected lifespan of 97. 
ACCEIXRATED F'ROGRESS 
There is no need  to  res t r ic t  the  calculations to  assumptions of a constant r a t e  of 
progress, however. A look a t  progress against m.ortality in the  previous decades of t h e  
t.wentieth century reveals t h a t  in the  1970s the  rates  of such progress were grea ter  
than in  previous decades a t  most ages. This acceleration may continue, and i t  is 
natural  t o  wonder what i ts continuation would m.ean for persons being born now. 
In fact,  when extrapolations a re  made based on t h e  acceleration of mortality pro- 
gress from the  1960s to  the  1970s, Anna's life expectancy increases to  93 years. When 
*The methods used in this paper are discussed in the Appendfix. 
we account  for acceleration in figuring male life expectancy, t h e  result  is 97 years, 
0 
which would finally give males a higher eo than females. Clearly this means tha t  pro- 
gress against male mortality accelerated greatly in the  1970s; little progress was made 
a t  most ages in t h e  1960s, and  a t  many ages mortality rates  in  fact increased. 
OTHER RATES OF PROGRESS 
A r ecen t  report  of the  Office of the  Actuary does make some conser-vative projec- 
tions of fu ture  progress against mortality, although even this  progress is riot taken 
in to  account  when figuring official estimates of life expectancy [2,3]. Since the  
actuarial figures do not go past t he  year 2050, we will assume mortality rates a t  all 
ages remain constant af ter  2050. Under these conditions A.13.'~ life expectancy is 83, 
some five years higher than the  official estimate. 
Mortality ra tes  improved a t  an average of almost 2 percent  per  year  in the  1970s. 
If the  2 percent  improvement ra te  is applied uniformly to all baby A.B.'s ages, he r  
expected lifespan is 102 years. The great  difference between this number and  the  90 
which resul ts  from extrapolating the cur rent  ra tes  of progress, which average 2 per- 
cent ,  is a t t r ibutable to  the  fact tha t  more people die a t  older a g e s  than a t  younger 
ages, whereas the  ra te  of progress against mortality tended to less than 2 percent  a t  
older ages and grea ter  than  2 percent  a t  younger ages. Even if progress against mor- 
tality i s  only 1 percent  per  year  a t  all ages, Anna can expect to  become an octo- 
0 
genarian with an eo of 87 years. 
Table 1. Various estimates of the life expectancy of a newborn. 
0 0 
Circumstances Baby A.B.'s eo Baby Boy's e o  
Official prediction 7 8 7 1 
Continued progress against 
mortality as in 1970s 90 8 1 
Progress continues to  accelerate 
as i t  did between 1960 and 1980 93 97 
Progress slows down as actuary projects 8 3 7 5 
Progress is 1 per cent every year 
a t  all ages 87 79 
Progress is 2 percent every year 
a t  all ages 102 94 
DISEASE-gY-DI!XWE PROGRESS 
But where specifically will this progress against mortality be made? Again, it 
seems reasonable to gain insight from extrapolating recen t  rates of progress against 
0 
the  several causes of death to see what A.B. will probably die from. Anna's eo turns  out 
to be 86 years after this extrapolation. 
As seen in Table 2, A.B. would be more likely to  die from hear t  disease than any 
other cause if cu r ren t  mortality rates persisted. If the rates of improvement against 
these causes continue, as t h e  right columns of the  table show, cancer will overtake all 
other causes of death and become t h e  leader. 
Some of these numbers may be surprising, but they are  explained by the ages a t  
which people die from these diseases today and the ages a t  which improvement is 
being made. For example, although many more people die from hear t  disease than 
from cancer today, and some progress is being made against cancer, most of tha t  pro- 
gress is made a t  younger ages, where the  chances of A.B. dying are relatively low; in 
the case of heart disease, progress is being made a t  older ages, when the  chances of 
he r  dying are high. In fact, while in recent years total average annual progress 
Table 2. What will a newborn eventually die from? 
Probability of dying from various causes 
Assuming no progress Continued progress 
Cause Female Male Female Male 
Heart disease 42% 40X 11% 9 % 
Cancer 
Vascular disease 
Violence 
Respiratory causes  
Congenital causes 
Digestive diseases 
Diabetes mellitus 
Liver cirrhosis 
Other causes 
Total 
against  h e a r t  disease for females was close t o  3 percent ,  i t  was slightly negative for 
cancer--that is, cancer  mortality actually increased. As i s  apparent  from the  even 
more ex t reme numbers  fo r  male mortality,  cance r  t rends  have been still more dismal 
for males, averaging near ly  a 1 percent  annual  increase.  
The probability of Anna dying from violent causes,  which include accidents,  homi- 
cides, and  suicides, is only a round 1 percent  and  may be unrealistically low, although 
t h e  point is debatable. The fact  is t h a t  g r e a t  progress has  been made against death by 
violence a t  most ages, especially older ages. The accident  dea th  ra te  among t h e  eld- 
erly is a good measure of how heal thy they  a re ,  and  s o  this  progress may be a sign of 
improvenlents in hea l th  among t h e  elderly. Extrapolating this  progress over A.B.'s life 
yields t h e  low value of 1 percent .  But if all disease were eliminated, everyone would 
have to  eventually die from violence, which would raise A.B.'s probability of dying from 
violence t o  100 percent .  
Models are  sometimes more useful for counter-prediction than for prediction. If 
we view a 1 percent probability of dying from violence as highly unlikely, then we must 
believe tha t  the rate of improvement cannot continue as it did in the  1970s. 
IF CANCER IS ELlMINATED 
Since cancer becomes such a major cause of death, i t  is natural to wonder how 
the  eradication of cancer would affect life expectancy. The conventional answer has 
been tha t  curing cancer would only increase expected lifespan by little more than two 
years [4]. This slight prediction of a cancer cure's impact is due to the  fact tha t  at 
current rates only about a fifth of males and females can expect to die from cancer. 
Like the conventional life expectancy estimates, however, this projection changes if 
we assume continued rates of progress against mortality. 
If we take the  cause-specific death rates projected above, most of which improve 
each year, and subtract the cancer mortality rates from each year of Anna's life, A.B.'s 
0 
eo increases to 96 years. This substantial increase of a fu1.l decade stems from the  
high chances, 44 percent, of Anna dying from cancer if current  progress against the 
various causes of death continues. Among males, where cancer becomes even more 
dominant, accounting for two-thirds of all deaths, i ts eradi-cation raises life expec- 
tancy from 74 t o  88. 
Eradicating today's number one killer, heart disease, only increases kB. 's  life 
expectancy from 86 to 87. A continuation of present; t rends in progress against mor- 
tality would mean that  heart  disease can be expected t o  become much less important, 
and thus its total elimination would do little to increase expected life span. Getting 
0 
rid of all cardiovascular disease, in fact, only raises Anna's eo  by two 
THE PROSPECIS FOR INCREASING LIFE EXPECTANCY 
The projections made here for baby AB.'s lifespan may seem overly optimistic, but 
they may eventually tu rn  out to be conservative if the  predictions of certain biomedi- 
cal scientists on fu ture  progress against mortality ra tes ,  and  even the  imminence of a 
breakthrough against aging itself, tu rn  out t o  be correct .  According to biologist 
Robert A. Weinberg of M.I.T., for example, the recent  advances in  genetic engineering 
will make great  strides possible against such ailments as  atherosclerosis, cancer ,  and  
diabetes both in our howledge  of what causes them and in our  ability to  t r ea t  them 
[4]. And U.C.L.A. gerontologist Roy Walford writes t h a t  his field is showing t h e  early 
signs of a scientific revolution, with several equally credible competing hypotheses 
about t he  aging process being offered [5]. 
One se t  of theories about aging assumes t h a t  t h e  process is caused by cellular 
damage. A number of medical scientists have done research  into t h e  oxygen free ra&- 
cals which form during normal metabolic processes a n d  which play a newly discovered 
role in cellular injury and perhaps in aging itself (e.g., [6, 7,8] ) .  Other scientists a re  
experimenting with increasing the  ra te  of cellular repair,  which they say will increase 
life span substantially. 
An a l te rna te  se t  of theories is based on the paradigm t h a t  aging is programmed 
into cells. One holds tha t  the  expression and repression of cer tain genes a t  cer tain 
ages is responsible for aging, and manipulation of this expression and repression could 
extend lifespan. Another says t h a t  the  body releases a destructive hormone a t  a 
predetermined time; this hormone may soon be identified. A third theory holds tha t  i t  
is the breakdown of the  immune syst.em which holds the  key to  extending life expec- 
tancy  [5]. 
If a revolution in t h e  biological sciences  does take place, by one of these theories 
or by a synthesis  of them,  t h e  demographic impact will be drastic,  with entirely new 
challenges presenting themselves t o  demographers and  to  society in general.  Imagine 
t he  social, economic, and  political consequences if Anna's life expectancy was 150 or 
even 200 years.  
Use of t h e  approximate formula for life expectancy, 
where q ( a )  is the mortality ra te  a t  age a ,  p ( a )  is the  probability of being alive a t  age 
a ,  and w is t h e  age beyond which no  one lives, shows what needs to  be calculated to 
0 
find baby A.B.'s eo .  In all of ou r  calculations reported here,  we took w t o  be 200 years .  
In no case would the  use of a higher  w (of, say, 250 years) make any difference in t he  
results;  in  nearly all cases, use of a lower w (of even 120) would not change the  resul ts  
by more than  a fraction of a year. 
Linear Progress Against Mortality: 
Using mortality ra tes  for age 0 through age 119 in  1970 and comparing them with 
their  1980 counterparts  [2 ,3]  allows extrapolat.ion of the  1970s ra tes  of progress over 
Anna's life. First each q ( a )  for Anna must be modified according to  the  rates  of pro- 
gress observed in the 1970s. If R ( a )  equals the progress multiplier, or the number by 
which we multiply an old mortality ra te  to get  a new mortality ra te ,  and sy ( a )  equals 
the mortality ra te  a t  age a in year  y ,  then 
The resulting number represents progress over an entire decade; i t  will be more useful 
to find progr-ess over a single year. Since the ra te  of progress over a decade is given 
simply by the annual rates  within tha t  decade multiplier together,  the average annual 
progress multiplier is found as  follows: 
To figure each s ( a )  for Anna B., simply use each R ( a )  raised t o  the appropriate 
power: 
The exponent must  be (a+4)  because Anna was born in  1984 ra ther  than 1980. 
Next the task is to  figure the probability Anria will be alive a t  age a .  The probabil- 
ity of her  living to age a equals the probability tha t  she lived t.o the previous age times 
the  mortality r a t e  for the previous age: 
where p (0) = 1. 
Now equation ( 1 )  yields Anna's life expectancy. 
Accelerated Progress: 
Just as before, dividing the rates  of progress against mortality for a later decade 
by those of an earlier decade and finding the tenth root of the result  gives the  average 
annual r a t e  of progress for each age. This average is probably not  exactly t rue  for any 
one year, but we can approximately represent i t  as applying to  the  midpoint of each 
decade: 
For most ages, R75(a) is less than Rgij(a);  t ha t  is, qBO(a) is less than by a 
greater  percentage than  is less than ~ ~ ~ ( a ) .  To find out by how much progress 
accelerated a t  each age, divide the  second decade's progress multiplier by the first 
decade's. As 1975 minus 1965 equals 10 years, raise the  acceleration ra te  to the one- 
ten th  power: 
A t  several ages, progress against mortality actually decelerated in the  1970s. We 
ignored this decelerati.on by changing the  acceleration ra te  from the negative number 
signi.fy-ing deceleration t o  0, signifying no acceleration. 
The next  task is to  find the  mortality rates ,  q ,  for each of Anna's ages. Baby A.B.'s 
q ' s  must be based on the  1980 q ' s  as modified by R75(a) and ~ ( a ) .  The mortality rate  
a t  age a for Anna is equal to the mortality rat,e for tha t  age in 1980 times the  rate of 
progress for tha t  age between 1980 and 1981, .times the  ra te  of progress between 1981 
and 1982, and so forth, until  the  year in question is reached: 
The answer to  what RBl(a)  and RBZ(a), etc., a re ,  lies in ~ ( a ) ,  the acceleration 
multiplier. The rate  of progress between 1980 and 1981 equals t h e  rate  of progress in 
1975, our most recent  and accurate figure, times the  acceleration multiplier raised t o  
the  fifth power ( to account for the  passage of five years). Likewise, RB1(a) is 
~ 7 5 b  ) X A  ( a  )6. 
Thus: 
It follows t h a t  
q ( a )  = qao(a )x[R75(a ) ( a + 4 ) ] x [ ~ ( a ) Z l  8 
where z is the  sum of the values of all exponerlts of A(a).  To find x ,  we use the  rule 
Gauss discovered as  a schoolboy for summing consecutive numbers. Note tha t  
which equals [(4x6) + (6x7)]/ 2. More generally, the  value of x is given by 
0 
The same equatiorls for p ( a )  and eo are  used as before. 
Using the Actuary k Estimates: 
The data on future mortality in the actuary's report is by decade rather  than  by 
year. Since mortality rates  improve every year ra ther  than  every t en  years, we must 
take the actuarial figures For each decade and interpolate yearly improvement. The 
projected r a t e  of progress against mortality must be found, using the  equations above. 
As a n  example, assume we a r e  given q ( 3 0 )  for t h e  year  2010 and  q ( 3 0 )  for 2020, 
but  not for any  years  in between. The yearly progress multiplier is t h e n  
R = [(q20(30) /  9 10(30))0'11 . 
Suppose we want q ( 3 0 )  in t h e  year  2014, t h e  yea r  Anna is 30. Now, q ( 3 0 )  in 2014 
equals q ( 3 0 )  in 2010 t imes t h e  yearly progress multiplier ra ised t o  t he  fourth power, t o  
account  for t he  passage of four years.  Thus Anna's mortality r a t e  is: 
C a u s e -  @ e c i f i c  M o r t a l i t y  R a t e s :  
We used  cause-specific period da ta  re leased by t h e  Office of the  Actuary on mor- 
tali ty r a t e s  in 1977 and  average annual  r a t e s  of improvement between 1968 and  1978. 
Although these  da ta  a re  period data, or slices of time, we can  use them to  figure ou t  
Anna's cause-specific mortality ra tes .  All we need  do is improve all t he  mortality ra tes  
for each disease through all of kB . ' s  life, using the  same annualepercentage improve- 
ments  as  were experienced in 1968-1978, t h e n  apply these r a t e s  to  Anna's lifetime. 
The data we use only includes mortality r a t e s  up  to  t h e  category 85+; for higher ages 
u p  to  119, we used total dea th  rates  subdivided, based on the  proportions in t h e  
category 85+. in to  t h e  t e n  causes; and  after age 119, we extrapolated t he  cause-  
specific mortali ty r a t e s  based on the  average annual  r a t e  of increase in mortali ty for 
ages 100 to 119. 
We encountered  a problem with t h e  cancer  ra tes ,  which becomes grea te r  than  1 
before age 200 because of t he  cont inued negative progress against  them. Therefore we 
worked with p, t h e  force of mortality, aft,er age 119, because i t  is acceptable for p t o  
become g rea t e r  t h a n  1. The formula we used  to  convert  q ' s  t o  p ' s  is: 
Before we figure life expectancy, we convert the  p's back to q 's ,  using the formula: 
q ( a )  = I - e - ~ ( = )  , 
EZiminating Cancer: 
Clearly, t he  f i r s t  s t ep  is to  subtract  the  cancer  death ra tes  from the  total death 
rates .  But here  again is a complication: by eliminating cancer ,  we must  account  for 
t he  increased exposure t o  t h e  o ther  diseases AB. experiences each year since she  did 
not  die from cancer .  In o ther  words, t he  death r a t e  after cancer  eradication equals 
t he  total death r a t e  minus the  cancer  death r a t e  plus t h e  additional death r a t e  caused 
by slightly increased exposure t o  other  causes of death. 
Since people die on t h e  average on July 1, we must allow for an additional half 
year of exposure to  non-cancerous causes of death. Therefore, lett ing q, denote 
cancer  mortality ra tes  and  q '  denote t he  total  mortality ra tes  after cancer  is eradi- 
cated,  
q ' ( a >  = s ( a >  - q, (a>  + s , ( a > x [ t g ( a )  - qc (a ) ) /21  (12) 
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